Oregon Public Employees Retirement Fund’s Collegium Pharmaceutical COLL Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$266K	Buy	7,361 +100	+1%	+$3.42K	﹤0.01%	1402
2026 Q1	$240K	Hold	7,261	–	–	﹤0.01%	1386
2025 Q4	$336K	Buy	7,261 +200	+3%	+$8.37K	﹤0.01%	1293
2025 Q3	$247K	Sell	7,061 -300	-4%	-$10.4K	﹤0.01%	1354
2025 Q2	$218K	Hold	7,361	–	–	﹤0.01%	1366
2025 Q1	$220K	Sell	7,361 -200	-3%	-$6.11K	﹤0.01%	1368
2024 Q4	$217K	Hold	7,561	–	–	﹤0.01%	1390
2024 Q3	$292K	Sell	7,561 -400	-5%	-$14.3K	0.01%	1318
2024 Q2	$256K	Sell	7,961 -800	-9%	-$27.7K	0.01%	1338
2024 Q1	$340K	Sell	8,761 -761	-8%	-$26.6K	0.01%	1291
2023 Q4	$293K	Sell	9,522 -800	-8%	-$20K	0.01%	1372
2023 Q3	$231K	Sell	10,322 -500	-5%	-$11.4K	﹤0.01%	1529
2023 Q2	$233K	Hold	10,822	–	–	﹤0.01%	1555
2023 Q1	$260K	Sell	10,822 -342	-3%	-$9.07K	﹤0.01%	1513
2022 Q4	$259K	Buy	11,164 +21	+0.2%	+$423	﹤0.01%	1517
2022 Q3	$179K	Hold	11,143	–	–	﹤0.01%	1583
2022 Q2	$197K	Sell	11,143 -2,060	-16%	-$34.7K	﹤0.01%	1415
2022 Q1	$269K	Sell	13,203 -300	-2%	-$5.67K	﹤0.01%	1566
2021 Q4	$252K	Sell	13,503 -600	-4%	-$11.7K	﹤0.01%	1486
2021 Q3	$278K	Sell	14,103 -100	-0.7%	-$2.16K	﹤0.01%	1466
2021 Q2	$336K	Sell	14,203 -1,232	-8%	-$28.5K	﹤0.01%	1429
2021 Q1	$366K	Buy	15,435 +14,203	+1,153%	+$337K	﹤0.01%	1404
2020 Q4	$25K	Hold	1,232	–	–	﹤0.01%	1597
2020 Q3	$26K	Hold	1,232	–	–	﹤0.01%	1573
2020 Q2	$22K	Sell	1,232 -6,900	-85%	-$135K	﹤0.01%	1575
2020 Q1	$133K	Sell	8,132 -8,133	-50%	-$168K	﹤0.01%	1433
2019 Q4	$335K	Buy	+16,265	New	+$271K	﹤0.01%	1342
2019 Q1	–	Sell	-6,000	Closed	-$103K	–	1647
2018 Q4	$103K	Buy	+6,000	New	+$103K	﹤0.01%	1623

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Oregon Public Employees Retirement Fund's COLL Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Collegium Pharmaceutical (COLL) stake by 1.4% in Q2 2026, buying an estimated $3.42K and bringing the position to 7,361 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #1402.

Oregon Public Employees Retirement Fund first reported a position in COLL in Q4 2018 and has held it in 28 quarters since. The position peaked at $366K in Q1 2021. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Oregon Public Employees Retirement Fund held 7,361 shares of Collegium Pharmaceutical worth $266K as of Q2 2026.
Oregon Public Employees Retirement Fund bought 100 Collegium Pharmaceutical shares in Q2 2026, an estimated $3.42K.
Collegium Pharmaceutical made up ﹤0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1402 holding.
Oregon Public Employees Retirement Fund first reported a position in Collegium Pharmaceutical in Q4 2018 and has held it in 28 quarters since.
Oregon Public Employees Retirement Fund's Collegium Pharmaceutical position peaked at $366K in Q1 2021.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.